TY - JOUR
T1 - Treatment of patients with restenosis
AU - Kornowski, R.
AU - Hong, M. K.
AU - Leon, M. B.
PY - 1998
Y1 - 1998
N2 - Restenosis after successful coronary balloon angioplasty (PTCA) or stenting, usually within the first 6 months, continues to be a major limitation and a therapeutic challenge. Recent studies have identified negative vascular remodeling (for nonstent transcatheter procedures) and neointimal hyperplasia (for in-stent restenosis) as the mechanisms of restenosis. New therapies, such as coronary stents, atheroablative devices, intracoronary irradiation, and local drug delivery, may improve the treatment of restenosis. This review article discusses the therapeutic options for patients with restenosis after coronary angioplasty or stent implantation.
AB - Restenosis after successful coronary balloon angioplasty (PTCA) or stenting, usually within the first 6 months, continues to be a major limitation and a therapeutic challenge. Recent studies have identified negative vascular remodeling (for nonstent transcatheter procedures) and neointimal hyperplasia (for in-stent restenosis) as the mechanisms of restenosis. New therapies, such as coronary stents, atheroablative devices, intracoronary irradiation, and local drug delivery, may improve the treatment of restenosis. This review article discusses the therapeutic options for patients with restenosis after coronary angioplasty or stent implantation.
UR - http://www.scopus.com/inward/record.url?scp=0031836061&partnerID=8YFLogxK
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
AN - SCOPUS:0031836061
SN - 1085-3324
VL - 3
SP - 79
EP - 90
JO - Contemporary Treatments in Cardiovascular Disease
JF - Contemporary Treatments in Cardiovascular Disease
IS - 2
ER -
